Thromboembolic prophylaxis.

OBJECTIVE: It has been evaluated during a longitudinal prospective study (ECHODIAH study) conducted over a 3-year period estimated the pertinence of total hip arthroplasty as an assessment criterion for the evaluation of the efficacy of structuromodulators. RESULTS: It is clear that patients who undergo total hip arthroplasty have more advanced hip disease. Factors predisposing to total hip arthroplasty have been demonstrated by multivariate analysis: advanced age, female gender, severe pain, Lequesne index, superolateral migration of the femoral head, important structural alterations. Other factors such as area of residence were not found to have any influence. Consequently, total hip arthroplasty appears to be a valid and reliable assessment criteria for degenerative hip disease.

Hip Prosthesis↗

PubMed2002

[When should the implantation of total hip prosthesis be considered in patients with coxarthrosis?].

COMPOSITE SCORE: The decision to perform total hip arthroplasty in patients with degenerative hip disease requires a homogeneous set of indications to determine as objectively as possible patient needs and priorities and to help the physician to indicate surgery appropriately. A NEW SCORING SYSTEM: To date, the different scores proposed have not taken into account the severity of the structural involvement nor the use of symptomatic treatments. A new composite score was thus developed using symptomatic, structural and therapeutic variables for osteoarthritis and its impact on quality of life. Cut-off value: A score of 40 is used as the cut-off value for indication of total hip arthroplasty with a sensitivity and specificity greater than 80%. Using values > or = 40, total hip arthroplasty is predictable in 54.3% of the patients.

Hip Prosthesis↗